APA ENRO 5 I

Description

COMPOSITION
Enrofloxacin, Excipients qs.

INDICATIONS
Treatment of alimentary, respiratory and urogenital tract infections (prostatitis, adjunctive antibiotic therapy for pyometra), skin and wound infections, otitis (externa/media) in dogs and cats caused by Staphylococcus spp., E. coli, Pasteurella spp., Klebsiella spp., Bordetella spp., Pseudomonas spp. and Proteus spp. susceptible to enrofloxacin.

DOSAGE AND ADMINISTRATION
1 ml of product/ 10 kg of body weight, corresponding to 5 mg of enrofloxacin/kg bw, daily by subcutaneous injection for up to 5 days.

CONTRAINDICATIONS
– Do not use in case of known hypersensitivity to any ingredients of the product.
– Do not use in pets that are epileptic or suffer from seizures.
– Do not use in young dogs during their growth, i.e. in small breeds of dogs less than 8 months of age, in big breeds of dogs less than 12 months of age, in giant breeds of dogs less than 18 months of age.
– Do not use in cats less than 8 weeks of age.
– Do not use enrofloxacin concomitantly with antimicrobial substances acting antagonistically to quinolones (e.g. macrolides, tetracyclines or phenicols) or theophylline.

WITHDRAWAL PERIOD
Not applicated.

STORAGE CONDITION
– Store in dry cool place, avoid direct sunlight.
– Store in room temperature, under 30⁰C.

FOR VETERINARY USE ONLY

“Do not contain substances banned in manufacturing veterinary trade, as regulated in current issuance of Ministry of Agriculture and Rural Development”